COVID-19 Data Initiative2021-02-08T17:22:00-05:00

News & Insights

Impact, observations, and insights to advance translational intelligence

Trends & Insights
COVID-19 Data Initiative
Press Releases
Conferences & Events

COVID-19-Related Data Aggregation Initiative for Drug Development

COVID-19 Data Initiative, Trends & Insights|

April 28, 2020 — COVID-19 is at the forefront of many research and development agendas. How can the integration of publicly available data help accelerate these efforts? The QuartzBio team is building and making available a unified SARS-CoV-2 / COVID-19 data ecosystem to support our own work and that of the broader research community. In the midst of the global pandemic, research and development teams face unprecedented operational hurdles affecting data generation.

COVID-19: Key Considerations for Ongoing Clinical Trials

COVID-19 Data Initiative, Trends & Insights|

April 1, 2020 — The global pandemic caused by COVID-19 is presenting a public health crisis, and unprecedented challenges in the conduct of clinical trials. The quickly realized disruption has motivated FDA and EMA to issue guidance in direct response. As we continue to adapt to the new reality, we are seeing proactive monitoring of strained health care systems and potential for shipping disruptions as top of mind issues for Sponsors operating ongoing trials. This is especially true as Sponsors work to maintain R&D momentum and continue to serve patients – while adapting to an increasingly remote workforce requiring virtual collaboration. (more…)

Load More Posts